In this article, we will discuss the 11 Most Undervalued Stocks to Buy According to Analysts
As per the US Bank, the US stock markets kicked off 2026 at record highs. However, the recent pullback demonstrates elevated levels of geopolitical risk due to the Iran conflict. This war raised the energy prices amidst disruption on the global trade routes. As of now, the broader markets are checking how long elevated costs will last against the favourable fiscal policy, reduced rates, and resilient profits.
There are several forces that are supporting the broader market outlook, added the US Bank. The fiscal policy is supportive, with the “One Big Beautiful Act’s” tax cuts and household tax relief helping cash flows.
Furthermore, the market leadership continues to expand beyond the narrow group of large IT and communication services stocks. The US Bank highlighted that cyclical sectors, mid-cap and small-cap stocks, and international markets made a significant contribution to returns in 2026.
The One Big Beautiful Bill Act slashed corporate and individual taxes. Therefore, the lower tax burdens are expected to help consumers in H1 2026, with estimates hinting at a net $127 billion consumer boost.
Amidst such trends, we will now have a look at the 11 Most Undervalued Stocks to Buy According to Analysts
Our Methodology
To list the 11 Most Undervalued Stocks to Buy According to Analysts, we used a screener to shortlist the companies that trade at a forward P/E of less than ~15x and in which analysts see atleast 20% upside. Finally, we selected the ones popular among hedge funds, as of Q4 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Note: All the data points are as of March 13, 2026
11 Most Undervalued Stocks to Buy According to Analysts
11. United Airlines Holdings, Inc. (NASDAQ:UAL)
United Airlines Holdings, Inc. (NASDAQ:UAL) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 16, UBS analyst Atul Maheswari reduced the firm’s price objective on the company’s stock to $134 from $147 and kept a “Buy” rating, as reported by The Fly. As per the analyst, a range of airline companies are anticipated to release early updates. The companies are expected to guide that their respective Q1 results will be towards the midpoint of their previous outlooks.
While the fuel prices witnessed an increase in early March, the limited inventory exposure can soften the blow to the EPS, while strong demand trends can lend some support to RASM.
In a separate release, Wells Fargo analyst Christian Wetherbee reduced the firm’s price objective on United Airlines Holdings, Inc. (NASDAQ:UAL)’s stock to $130 from $145, while keeping an “Overweight” rating. Over the previous few weeks, the firm noted fuel risk. It had also lowered the estimates. That being said, robust demand is expected to offset the impact. However, there can be guidance cuts, added Wells Fargo.
United Airlines Holdings, Inc. (NASDAQ:UAL) is a holding company that provides transportation services, operating across the Atlantic, Pacific, and Latin American regions.
10. Morgan Stanley (NYSE:MS)
Morgan Stanley (NYSE:MS) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 11, Bloomberg reported that Morgan Stanley (NYSE:MS) and Cliffwater LLC capped withdrawals from multibillion-dollar private credit funds. This move came after investors decided to redeem significantly more than the permitted limit. Morgan Stanley (NYSE:MS)’s North Haven Private Income Fund, with ~$8 billion in assets, had to return ~$169 million, or less than half of the investors’ tender requests. This was after the company capped redemptions at 5% of shares.
As per Bloomberg, in a letter to its clients, Morgan Stanley (NYSE:MS) hinted at challenges that the private credit industry has been grappling with. These include a contraction in asset yields and uncertainty related to the M&A environment. That being said, the company expects that some of the pressures might ease soon. As of January 31, North Haven had over $2.2 billion of liquidity and 8.9% annualized net return over 3 years.
Morgan Stanley (NYSE:MS) is a global financial services company that provides a range of investment banking, securities, wealth management, and investment management services to corporations, financial institutions, governments, and individuals.
9. Salesforce, Inc. (NYSE:CRM)
Salesforce, Inc. (NYSE:CRM) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 10, Northland analyst Nehal Chokshi reduced its price objective on Salesforce, Inc. (NYSE:CRM)’s stock to $229 from $267, while keeping a “Market Perform” rating. As per the analyst, the company reported its Q4 2026 cRPO of $35.1 billion, reflecting a rise of 16.2% YoY.
Notably, it was still below the key 10% – 12% levels, considering 9% growth on a constant currency organic basis. This is arrived after deducting 4% revenue growth due to the Informatica acquisition. While the firm trimmed its valuation multiple, it also highlighted that the $50 billion debt-funded buyback announcement is a positive move.
In a different update, Salesforce, Inc. (NYSE:CRM)’s Q4 2026 subscription & support revenue came in at $10.7 billion, reflecting a rise of 13% YoY and 11% in constant currency, including the $388 million Informatica contribution. The company expects revenue of between $45.8 billion – $46.2 billion in FY 2027, reflecting a rise of 10% – 11% YoY and in constant currency, including ~3pts contribution from Informatica.
Salesforce, Inc. (NYSE:CRM) focuses on developing cloud-based customer relationship management software that includes solutions for sales, service, marketing, commerce, and analytics, as well as AI, automation, and data tools to assist businesses in managing client interactions.
8. Adobe Inc. (NASDAQ:ADBE)
Adobe Inc. (NASDAQ:ADBE) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 13, Barclays downgraded the company’s stock to “Equal Weight” from “Overweight” with a price objective of $275, down from the prior target of $335, as reported by The Fly. As per the analyst, the company’s net new annual recurring revenue was below the estimates. The firm believes that the biggest news is that Adobe Inc. (NASDAQ:ADBE)’s long-time CEO is transitioning out.
As per the firm, faster growth in freemium users for products such as Firefly and Express has been impacting ARPU. That being said, this can act in the company’s favour, considering Adobe Inc. (NASDAQ:ADBE)’s success with Acrobat Reader, which was its original freemium product, added Barclays.
In a separate release, Adobe Inc. (NASDAQ:ADBE) saw 13% subscription revenue growth and a strong Q1 2026 cash flow of $2.96 billion. For Q2 2026, the company expects total revenue of between $6.43 billion – $6.48 billion and EPS (GAAP) of between $4.35 to $4.40.
Adobe Inc. (NASDAQ:ADBE) delivers digital marketing, media, and customer experience solutions across its Digital Media, Digital Experience, and Publishing/Advertising segments. The company is based in San Jose, California.
7. CVS Health Corporation (NYSE:CVS)
CVS Health Corporation (NYSE:CVS) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 12, Bernstein analyst Lance Wilkes upgraded the company’s stock to “Outperform” from “Market Perform” with a price objective of $94, an increase from the prior target of $91. This upgrade demonstrates CVS Health Corporation (NYSE:CVS)’s attractive exposure to the Medicare Advantage turnaround and expectations of stable earnings in the pharmacy and pharmacy benefit manager businesses after the reforms.
According to the analyst, the PBM bill passage and the first Federal Trade Commission settlement with Cigna act as the clearing event for the company’s stock.
In a different update, CVS Health Corporation (NYSE:CVS) and Google Cloud announced a strategic partnership, targeting the reimagining of health care experiences, increasing consumer engagement, and helping better health outcomes. The company’s launch of Health100, which is a health technology services subsidiary, remains central to this partnership. With Health100, the company offers the future of agentic, AI-powered health care.
CVS Health Corporation (NYSE:CVS), a diversified healthcare company, combines insurance, pharmacy benefit management, retail pharmacies, and clinical services to provide integrated healthcare solutions throughout the United States via its vertically integrated platform.
6. SLB N.V. (NYSE:SLB)
SLB N.V. (NYSE:SLB) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 11, the company released an update about Q1 2026 outlook, with SLB N.V. (NYSE:SLB) expecting to incur additional costs. This can result in an impact of ~6 – 9 cents of earnings per diluted share for Q1 2026. SLB N.V. (NYSE:SLB) also noted that its revenue for the quarter will be lower than anticipated.
However, despite the challenges, SLB N.V. (NYSE:SLB) is confident in the underlying resilience of the global business, which includes the Middle East. It possesses significant experience in navigating the challenges whilst focusing on its global customer base.
In a different update, Bernstein analyst Guillaume Delaby lifted the firm’s price objective on SLB N.V. (NYSE:SLB)’s stock to $56.10 from $52.30, while keeping an “Outperform” rating. Notably, the firm adjusted its model after the company announced that it expects lower revenue in Q1 2026.
SLB (NYSE:SLB) provides technology for the energy industry worldwide. It operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems.
Click to continue reading and see the 5 Most Undervalued Stocks to Buy According to Analysts.
Disclosure: None. Follow Insider Monkey on Google News.
